Welcome Our New Distributor Partner!

22/04/2021

Omixon is pleased to announce a new distribution agreement with Syngen Biotech Sp. Z o.o. Sp. K. – a leading distributor of comprehensive equipment for laboratories throughout Poland. Syngen Biotech has been in the Polish market specializing in providing several high-class research equipment, diagnostics tests, reagents and offering application...

EFI Annual Meeting 2021

09/03/2021

EFI 2021 | From Research To Clinical Reality The registration is already open, you can register and find more info HERE. The planned detailed program is available HERE. In order to arrange one-to-one discussions with any of our representatives, please contact them either in advance by sending an email to sales@omixon.com or on the...

“High Throughput HLA Typing Approaches Using NGS” – Omixon Talk in Moscow

09/03/2020

Join Omixon for our talk at the Registries of Bone Marrow Donors: Today and Tomorrow conference in Moscow, Russia on March 12! The talk will be presented by Nina Lauterbach, PhD, Senior Field Application Scientist at Omixon. Date: Thursday, March 12, 2020 Venue: Center for the Development of Charity...

Interview with the South African National Blood Service

28/02/2020

The following interview is part of our interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. This time Dr. Lavendri Govender and Dr. Ute Jentsch from South-African National Blood Service talk about their experiences and thoughts on technology improvements. We...

Announcement – First Omixon Shipment to Kazakhstan

24/02/2020

We are pleased to inform our customers that Omixon have now officially shipped the first Holotype HLA kits for commercial sale to Nur-Sultan, Kazakhstan with the help of our local partner, Dilen s.r.o., our exclusive distributor in the country. “Our national reach and full technical support is now...